Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
Real-world data show oral immunotherapy for peanut allergy is safe, effective in infants
In a real-world setting, peanut oral immunotherapy was safer in infants aged 12 months or younger than in children aged 1 to 5 years, according to recent data.
Eosinophilia linked to better COVID-19 outcomes when patients use inhaled corticosteroids
Patients with high eosinophil counts experienced improved COVID-19 outcomes when they received inhaled corticosteroids, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Log in or Sign up for Free to view tailored content for your specialty!
Oral immunotherapy may lead to remission of peanut allergy in young children
Oral immunotherapy was associated with an increase in both desensitization and remission of peanut allergy among children aged younger than 4 years, with younger children seeing greater success, according to data published in The Lancet.
Asthma severity tied to more severe COVID-19 outcomes
In a new study, all asthma phenotypes were associated with risk for more severe COVID-19 outcomes, except for type 2 inflammation, researchers reported in the American Journal of Respiratory and Critical Care Medicine.
Hazelnut oral immunotherapy appears effective for children
Oral immunotherapy appeared effective and well-tolerated by children with hazelnut allergy, according to a retrospective study published in Annals of Allergy, Asthma & Immunology.
Sesame allergy often resolves in patients with mild reactions at young ages
Researchers found that sesame allergy spontaneously resolved in approximately one-third of patients who had a mild first reaction at a young age, according to a study published in Annals of Allergy, Asthma & Immunology.
Treatment for septal deviation may lower incidence of asthma
Septal deviation may be a treatable trait of asthma, with septoplasty reducing the risk, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Adherence to asthma medication over time important for improving symptom control
In a new study, novel metrics showed that lower time adherence to asthma controller medications was associated with greater risk for decline in asthma symptom control.
FDA approves Ryaltris nasal spray for seasonal allergic rhinitis
The FDA approved olopatadine hydrochloride and mometasone furoate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years and older, according to a press release.
Exercise interventions improve symptoms, quality of life for people with asthma
Interventions that promote physical activity could improve symptoms and quality of life for people with asthma, although these interventions may face barriers to success, according to a review published in Journal of Health Psychology.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read